Cargando…
Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis
INTRODUCTION: The purpose of this study was to determine if oral administration of the interleukin (IL) 12/IL-23 inhibitor, STA-5326, is effective in experimental autoimmune uveoretinitis (EAU). METHODS: C57BL/6J mice were immunised with human interphotoreceptor retinoid binding protein peptide (IRB...
Autores principales: | Keino, Hiroshi, Watanabe, Takayo, Sato, Yasuhiko, Niikura, Mamoru, Wada, Yumiko, Okada, Annabelle A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592812/ https://www.ncbi.nlm.nih.gov/pubmed/18847496 http://dx.doi.org/10.1186/ar2530 |
Ejemplares similares
-
IFN-β Inhibits the Increased Expression of IL-9 during Experimental Autoimmune Uveoretinitis
por: Yang, Yan, et al.
Publicado: (2012) -
Abrogation of Rbpj Attenuates Experimental Autoimmune Uveoretinitis by Inhibiting IL-22-Producing CD4(+) T Cells
por: Bhuyan, Zaied Ahmed, et al.
Publicado: (2014) -
The Microbiota Determines Susceptibility to Experimental Autoimmune Uveoretinitis
por: Heissigerova, Jarmila, et al.
Publicado: (2016) -
Osteopontin is a biomarker for early autoimmune uveoretinitis
por: Kim, Jeongtae, et al.
Publicado: (2021) -
AAV2-Mediated Combined Subretinal Delivery of IFN-α and IL-4 Reduces the Severity of Experimental Autoimmune Uveoretinitis
por: Tian, Lichun, et al.
Publicado: (2012)